Wells Pharma of Houston LLC recalls fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride
- Recalling company
- Wells Pharma of Houston LLC
- Product
- fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 50 mcg/5mL)(10 mcg per mL), wells pharma, NDC 73702-202-15.
- Reason
- cGMP deviations.
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- Apr 1, 2026
- Reported
- May 6, 2026
- Distribution
- U.S. Nationwide.
- Status
- Ongoing
- Quantity
- 50 syringes
- Lot / codes
- Lot 020226202150202, Exp Date 05/05/2026.
- Company location
- Houston, TX
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0508-2026
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0508-2026 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.